U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H34O2
Molecular Weight 318.4935
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BREXANOLONE

SMILES

[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@@]4([H])C[C@H](O)CC[C@]34C

InChI

InChIKey=AURFZBICLPNKBZ-SYBPFIFISA-N
InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1

HIDE SMILES / InChI

Molecular Formula C21H34O2
Molecular Weight 318.4935
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 08:10:21 UTC 2023
Edited
by admin
on Sat Dec 16 08:10:21 UTC 2023
Record UNII
S39XZ5QV8Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BREXANOLONE
INN   USAN  
Official Name English
ALLOPREGNAN-3.ALPHA.-OL-20-ONE [MI]
Common Name English
brexanolone [INN]
Common Name English
Brexanolone [WHO-DD]
Common Name English
ALLOTETRAHYDROPROGESTERONE
Common Name English
3α-Hydroxy-5α-pregnan-20-one
Systematic Name English
BREXANOLONE [ORANGE BOOK]
Common Name English
PREGNAN-20-ONE, 3-HYDROXY-, (3.ALPHA.,5.ALPHA.)-
Systematic Name English
SGE-102
Code English
(+)-3.ALPHA.-HYDROXY-5.ALPHA.-PREGNAN-20-ONE
Systematic Name English
ALLOPREGNAN-3.ALPHA.-OL-20-ONE
MI  
Common Name English
BREXANOLONE [USAN]
Common Name English
ALLOPREGNANOLONE
Common Name English
SAGE-547
Code English
ZULRESSO
Brand Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 426114
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
FDA ORPHAN DRUG 399013
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
Code System Code Type Description
INN
10446
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
FDA UNII
S39XZ5QV8Y
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
DRUG CENTRAL
5324
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
NCI_THESAURUS
C169815
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
CHEBI
50169
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
USAN
DE-17
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
RXCUI
2121777
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
MERCK INDEX
m1537
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY Merck Index
SMS_ID
100000177178
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
EPA CompTox
DTXSID901016239
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
DAILYMED
S39XZ5QV8Y
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
WIKIPEDIA
ALLOPREGNANOLONE
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
DRUG BANK
DB11859
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
CAS
516-54-1
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
LACTMED
Brexanolone
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
PUBCHEM
92786
Created by admin on Sat Dec 16 08:10:21 UTC 2023 , Edited by admin on Sat Dec 16 08:10:21 UTC 2023
PRIMARY
Related Record Type Details
EXCRETED UNCHANGED
Following administration of radiolabeled brexanolone, 47% was recovered in feces (primarily as metabolites) and 42% in urine (with less than 1% as unchanged brexanolone).
URINE
METABOLIC ENZYME -> SUBSTRATE
TARGET -> ACTIVATOR
MODULATOR
ALLOSTERIC
BINDER->LIGAND
Plasma protein binding was greater than 99% and is independent of plasma concentrations.
BINDING
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC